Fulgent Genetics has a low Price/Book ratio and promising drug candidates. Key trial results are expected in May 2025. Read ...

The third of four looks at how specific accounting firm niches are being impacted — for good and ill — by artificial ...

On March 12, 2025, the staff of the Division of Corporation Finance at the Securities and Exchange Commission (SEC) issued a no-action letter ...

Sprinklr's forward guidance shows tepid revenue growth but significant improvements in non-GAAP operating income and net ...

Team Buffett sold about 67% of its stake in Apple Inc. AAPL in 2024, selling most of it in the first three quarters of the ...

Capricor Therapeutics (CAPR) released expectation-beating results for the fourth quarter, sending the shares up over 5% in aftermarket trading.

Knight Therapeutics Inc. ("Knight" or "the Company"), a pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its fourth quarter and year ended December 31, 2024.

We will begin the MacroGenics fourth quarter and full year 2024 corporate progress and financial results conference call in just a moment. All participants are in a listen-only mode, and we will ...

For this ratio, current assets include cash, cash equivalents, inventory, marketable securities ... but a ratio that's way above 1, for example 4, means that a company has enough in current ...

Examples of current assets include ... They included cash and cash equivalents, short-term investments, marketable securities, accounts receivable, inventories, and prepaid expenses.

Google Cloud’s Wiz purchase for $32 billion will spur AI and cloud security innovation, Microsoft and AWS competition, and ...

Motherson Group, an existing shareholder and one of the world’s leading automotive suppliers, has been invited to invest up to $10 million in a second closing for a fully subscribed round by no later ...